Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.
Although obese individuals are at greater risk of diabetes, high blood pressure or high cholesterol, not all obese people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback